Community Research and Development Information Service - CORDIS

Results 1 - 10 of 218
Order by: Results/page:
12 3 4 5 6 7 8 9 10 > >| 
European Bank for induced pluripotent Stem Cells
ID: 115582
Start date: 2014-01-01, End date: 2017-12-31
EBiSC is designed to address the increasing demand by iPSC researchers for quality-controlled, disease-relevant research grade iPSC lines, data and cell services. Its goal is to demonstrate an operational banking and distribution service of iPSC lines after 3 years and to est...
Programme: FP7-JTI
Record Number: 203673
Last updated on: 2018-01-08
Aetionomy – Organising Mechanistic Knowledge about Neurodegenerative Diseases for the Improvement of Drug Development and Therapy
ID: 115568
Start date: 2014-01-01, End date: 2018-12-31
IMI’s Call 8 is geared to develop knowledge frameworks for ‘druggable mechanisms’ for two domains of pathophysiology. In response to this call, we propose (I) the development of a generic AETIONOMY pipeline to capture and infer over mechanistic knowledge of pathophysiology, a...
Programme: FP7-JTI
Record Number: 203715
Last updated on: 2018-01-08
Molecular Reclassification to Find Clinically Useful Biomarkers for Systemic Autoimmune Diseases
ID: 115565
Start date: 2014-02-01, End date: 2019-01-31
We concur to the IMI on “Reclassification of SLE, connective tissue diseases and RA” call by presenting a proposal aimed at using the power of OMICs, and bioinformatics to identify new classifications for diseases known to share common pathophysiological mechanisms. Such know...
Programme: FP7-JTI
Record Number: 203714
Last updated on: 2018-01-08
European Medical Information Framework
ID: 115372
Start date: 2013-01-01, End date: 2018-06-30
In response to the need to tackle increasingly complex medical research questions, a growing amount of human health data is being collected, either in routine Electronic Healthcare Record (EHR) databases, through research-driven cohort studies, in biobanks or related efforts....
Programme: FP7-JTI
Record Number: 203707
Last updated on: 2018-01-08
Thermochemical HYDROgen production in a SOLar monolithic reactor: construction and operation of a 750 kWth PLANT
ID: 325361
Start date: 2014-01-01, End date: 2018-04-30
The HYDROSOL-PLANT project is expected to develop, verify and operate all of the tools required to scale up solar H2O splitting to the pilot (750 kWth) scale. The work will be based on the successful HYDROSOL series projects and mainly on the outcome of the current FCH-JU co-...
Programme: FP7-JTI
Record Number: 111501
Last updated on: 2018-01-03
Anti-Biopharmaceutical Immunization:Prediction and analysis of clinical relevance to minimize the risk
ID: 115303
Start date: 2012-03-01, End date: 2018-02-28
The ABIRISK project provides an integrated approach to the study of immunization against biopharmaceuticals, bringing together a unique panel of experts from different disciplines. ABIRISK will involve many of the European leaders in rheumatology, gastroenterology, hemophilia...
Programme: FP7-JTI
Record Number: 203697
Last updated on: 2017-12-18
Accelerated Development of Vaccine benefit-risk  Collaboration in Europe
ID: 115557
Start date: 2013-10-01, End date: 2018-09-30
Aim: The ADVANCE vision is focused on Timely and Best Evidence on Vaccine Effects. Our mission is to establish a best practice framework to rapidly provide robust data on vaccine benefits and risks to support accelerated decision-making. Approach: To achieve this vision throu...
Programme: FP7-JTI
Record Number: 203713
Last updated on: 2017-12-18
Molecular basis of the outer membrane permeability
ID: 115525
Start date: 2013-01-01, End date: 2018-06-30
Overcoming the barriers that the cell envelope and efflux pumps provide to Gram-negative bacteria is a major bottleneck in the discovery and development of new antibiotics. To respond to this Call we are extending our current network on antibiotic translocation and propose an...
Programme: FP7-JTI
Record Number: 203712
Last updated on: 2017-12-07
Applied Public-Private Research enabling OsteoArthritis Clinical Headway
ID: 115770
Start date: 2015-06-01, End date: 2020-11-30
The problem: finding the right patient for the right treatment Despite a large and growing disease burden in osteoarthritis (OA), many pharmaceutical companies have de-emphasized or even abandoned OA drug development due to perceived hurdles. Crucial in this is the lack of ap...
Programme: FP7-JTI
Record Number: 203727
Last updated on: 2017-12-04
Model-based preclinical development of anti-tuberculosis drug combinations
ID: 115337
Start date: 2012-05-01, End date: 2017-10-31
Drug development in TB requires new integrated methods to transition the novel combination regimens needed to shorten first-line therapy and combat multi-drug resistance. Although new agents are emerging, the path to registration of such regimens remains uncertain while capac...
Programme: FP7-JTI
Record Number: 203702
Last updated on: 2017-12-04
12 3 4 5 6 7 8 9 10 > >| 
List retrieved on: 2018-04-22
Follow us on: RSS Facebook Twitter YouTube Managed by the EU Publications Office Top